Universal Ibogaine Inc.

IBOGFOTCHealthcare● Active

$0.03

$-0.00(-0.16%)

Market Cap$9808114

P/E Ratio—

52W High$0.35

52W Low$0.0023

Avg Volume1.4M

Open$0.03

Beta4.37

Earnings Financials Revenue

Universal Ibogaine Inc. (IBOGF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

IBOGF · earnings · updated Jun 15, 2026

No earnings history available.

Next Earnings Date

Days Away

days

Expected Date

Sep 2, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away79

Expected DateSep 2, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q1 FY2026	Jan 9, 2026	—	—	—	—	—	—

Q1 FY2026

Jan 9, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for IBOGF.

About Earnings & Data Methodology

Universal Ibogaine Inc. (IBOGF) reports earnings quarterly as a OTC-listed Biotechnology company. The next IBOGF earnings date is expected around September 2, 2026.

Each quarter, investors track IBOGF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IBOGF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

IBOGF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

IBOGF earnings · 3 questions

Universal Ibogaine Inc.'s next earnings report is expected around September 2, 2026. IBOGF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IBOGF historically reports after market close (AMC).

IBOGF earnings datewhen is IBOGF earningsIBOGF next earnings datewhen does IBOGF report earningsIBOGF earnings calendar

▸ Source: FMP · Universal Ibogaine Inc. SEC filings · US GAAP · Universal Ibogaine Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026